Publications by authors named "Ravikumar Muthuswamy"

Claim this Profile
I
IFNγ-mediated suppression of alternative NF-κB in tumor-resident myeloid cells promotes selective recruitment of cytotoxic but not regulatory T cells.
Adam Brinkman, Ravikumar Muthuswamy, Bowen Dong, Robert P Edwards, Pawel Kalinski

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells Aryl Hydrocarbon Receptor Activation.
Adaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, Han Yu, Tao Liu

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR6 by increasing retention of memory CD8 T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
Ravikumar Muthuswamy, Aj Robert McGray, Sebastiano Battaglia, Wenjun He, Anthony Miliotto

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment.
Marie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, Brian Orr, Ravikumar Muthuswamy

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.
Nataša Obermajer, Julie Urban, Eva Wieckowski, Ravikumar Muthuswamy, Roshni Ravindranathan

Nat Protoc· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues.
Ravikumar Muthuswamy, Nana J Okada, Frank J Jenkins, Kandace McGuire, Priscilla F McAuliffe

Brain Behav Immun· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses.
Narges Seyfizadeh, Ravikumar Muthuswamy, Duane A Mitchell, Stefan Nierkens, Nayer Seyfizadeh

Crit Rev Oncol Hematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
Ravikumar Muthuswamy, John M Corman, Kathryn Dahl, Gurkamal S Chatta, Pawel Kalinski

Prostate· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.
Ravikumar Muthuswamy, Liwen Wang, Jamie Pitteroff, Jeffrey R Gingrich, Pawel Kalinski

J Immunother Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients.
Jeffrey L Wong, Ravikumar Muthuswamy, David L Bartlett, Pawel Kalinski

Oncoimmunology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
Pawel Kalinski, Ravikumar Muthuswamy, Julie Urban

Expert Rev Vaccines· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.
Erik Berk, Ravikumar Muthuswamy, Pawel Kalinski

Vaccine· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.
Ravikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, Herbert J Zeh, Amer H Zureikat

Cancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA.
Naoki Umemura, Jianzhong Zhu, Yvonne K Mburu, Adriana Forero, Paishiun N Hsieh, Ravikumar Muthuswamy

Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
Natasa Obermajer, Ravikumar Muthuswamy, Kunle Odunsi, Robert P Edwards, Pawel Kalinski

Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MKP-1 signaling translates innate signals into adaptive responses.
Erik Berk, Ravikumar Muthuswamy

Immunotherapy· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell tolerance induced by non-Treg T-cell-derived TGF-β1.
Erik Berk, Ravikumar Muthuswamy

Immunotherapy· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treg-mediated angiogenesis and tolerance is programmed by hypoxia in the tumor microenvironment.
Erik Berk, Ravikumar Muthuswamy

Immunotherapy· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.
Natasa Obermajer, Ravikumar Muthuswamy, Jamie Lesnock, Robert P Edwards, Pawel Kalinski

Blood· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.
Ravikumar Muthuswamy, Jan Mueller-Berghaus, Uwe Haberkorn, Todd A Reinhart, Dirk Schadendorf

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells.
Pawel Kalinski, Eva Wieckowski, Ravikumar Muthuswamy, Esther de Jong

Methods Mol Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.
Payal B Watchmaker, Erik Berk, Ravikumar Muthuswamy, Robbie B Mailliard, Julie A Urban

J Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.
Kotaro Sasaki, Angela D Pardee, Yanyan Qu, Xi Zhao, Ryo Ueda, Ravikumar Muthuswamy

J Immunother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.
Pawel Kalinski, Julie Urban, Rahul Narang, Erik Berk, Ewa Wieckowski, Ravikumar Muthuswamy

Future Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.
Mitsugu Fujita, Xinmei Zhu, Ryo Ueda, Kotaro Sasaki, Gary Kohanbash, Ravikumar Muthuswamy

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis